$0.03
+0.00%Price chart
Sep 8Sep 14Sep 22Sep 29Oct 2Oct 7Oct 13Oct 19
Key dataOct 19, 2026
Open$0.03
From 52W high−88.89%
Volume887.00
Market cap$804540.00
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataOct 19, 2026
Open
$0.03
From 52W high
−88.89%
Volume
887.00
Market cap
$804540.00
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
P/E (TTM)
—
RSI (14)
33.6
MomentumView details →
1D Return
+0.00%
YTD Return
—
Similar companies
Latest newsMore news →
Veraxa Biotech Holding AG presented first in vivo proof-of-concept data for its BiTAC®-ADC technology at the World ADC Congress, showing tumor-selective activation, potent anti-tumor efficacy and improved safety.7d agoVERAXA Biotech is shifting focus to advancing its oncology pipeline and implementing industrial partnerships for its technology platforms and products after completing its business combination and starting Nasdaq trading in June 2026.26d agoVERAXA Biotech announced a collaboration with Ardigen to support its BiTAC pipeline of T cell engagers and antibody drug conjugates.99d ago